Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigma Pharmaceutical Industries is a prominent Egyptian pharmaceutical company founded in 1997 by Dr. El-Sayed El-Badawi. Headquartered in Quesna, Egypt, the company is a major manufacturer of generic medications, specializing in therapeutic areas such as metabolic disorders, respiratory health, and gastroenterology. It is widely recognized for its weight loss brand Diet Max (historically containing sibutramine) and other prominent Egyptian brands like Congestal and Aciloc. Sigma operates advanced manufacturing facilities, including the Sigmatec plant in 6th of October City, and has a significant presence across the Middle East and North Africa (MENA) region through various subsidiaries. The company focuses on delivering high-quality, affordable healthcare solutions and continues to expand its regional footprint through strategic acquisitions and partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diet Max Sigma.